Clinical trial
Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in…
NCT00306527 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00306527 |
|---|---|
| Title | Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly |
| Official title | A Phase III, Observer-Blind, Randomized, Multi-Center Study to Evaluate Safety, Tolerability and Immunogenicity (in a Subset) Following a Single Intramuscular Dose of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs, in Healthy Adult and… |
| Lead sponsor | Novartis Vaccines, Industry |
| Collaborators | Novartis Vaccines and Diagnostics S.r.l. |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Cell culture derived influenza vaccine, egg-derived influenza subunit vaccine |
| Enrollment | 2,235 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Mar 24, 2006 |
| Last update posted | Aug 14, 2019 |
| Countries | Poland |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: